Biora Therapeutics, Inc. (BIOR)

USD 0.22

(0.0%)

Total Assets Summary of Biora Therapeutics, Inc.

  • Biora Therapeutics, Inc.'s latest annual total assets in 2023 was 31.21 Million USD , down -41.68% from previous year.
  • Biora Therapeutics, Inc.'s latest quarterly total assets in 2024 Q2 was 18.26 Million USD , down -20.56% from previous quarter.
  • Biora Therapeutics, Inc. reported annual total assets of 53.52 Million USD in 2022, down -50.82% from previous year.
  • Biora Therapeutics, Inc. reported annual total assets of 108.83 Million USD in 2021, down -29.53% from previous year.
  • Biora Therapeutics, Inc. reported quarterly total assets of 22.99 Million USD for 2024 Q1, down -26.35% from previous quarter.
  • Biora Therapeutics, Inc. reported quarterly total assets of 49.67 Million USD for 2023 Q2, down -6.71% from previous quarter.

Annual Total Assets Chart of Biora Therapeutics, Inc. (2023 - 2018)

Historical Annual Total Assets of Biora Therapeutics, Inc. (2023 - 2018)

Year Total Assets Total Assets Growth
2023 31.21 Million USD -41.68%
2022 53.52 Million USD -50.82%
2021 108.83 Million USD -29.53%
2020 154.44 Million USD 51.82%
2019 101.72 Million USD -12.6%
2018 116.39 Million USD 0.0%

Peer Total Assets Comparison of Biora Therapeutics, Inc.

Name Total Assets Total Assets Difference
America Great Health 299.12 Thousand USD -10335.297%
Ampio Pharmaceuticals, Inc. 5.73 Million USD -444.195%
Aridis Pharmaceuticals, Inc. 14.69 Million USD -112.419%
Bio-Path Holdings, Inc. 3.22 Million USD -869.41%
Better Therapeutics, Inc. 22.94 Million USD -36.055%
Calithera Biosciences, Inc. 28.67 Million USD -8.854%
Comera Life Sciences Holdings, Inc. 3.72 Million USD -737.512%
Gene Biotherapeutics, Inc. - USD -Infinity%
eFFECTOR Therapeutics, Inc. 20.54 Million USD -51.942%
Eloxx Pharmaceuticals, Inc. 21.12 Million USD -47.777%
Evelo Biosciences, Inc. 64.44 Million USD 51.56%
Evolutionary Genomics, Inc. 2.35 Million USD -1226.204%
Finch Therapeutics Group, Inc. 70.99 Million USD 56.033%
Galera Therapeutics, Inc. 26.14 Million USD -19.41%
Innovation1 Biotech Inc. 75.99 Thousand USD -40976.152%
Kiromic BioPharma, Inc. 12.16 Million USD -156.512%
Molecular Templates, Inc. 35.38 Million USD 11.78%
Navidea Biopharmaceuticals, Inc. 4.37 Million USD -614.04%
NexImmune, Inc. 8.59 Million USD -263.221%
Orgenesis Inc. 14.55 Million USD -114.507%
Panbela Therapeutics, Inc. 11.8 Million USD -164.489%
Point of Care Nano-Technology, Inc. 124.64 Thousand USD -24943.524%
PaxMedica, Inc. Common Stock 5.68 Million USD -449.521%
Scopus BioPharma Inc. 392.26 Thousand USD -7857.631%
Sorrento Therapeutics, Inc. 472.84 Million USD 93.398%
Statera Biopharma, Inc. 21.16 Million USD -47.451%
TRACON Pharmaceuticals, Inc. 10.1 Million USD -208.906%
Trevena, Inc. 40.6 Million USD 23.125%
Vaxxinity, Inc. 44.35 Million USD 29.621%
Vaccinex, Inc. 3.63 Million USD -759.681%
Vicapsys Life Sciences, Inc. 39.65 Thousand USD -78614.444%
Viracta Therapeutics, Inc. 56.69 Million USD 44.939%
ZIVO Bioscience, Inc. 555.71 Thousand USD -5517.088%